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Abstract
Introduction Pneumothorax often complicates the management
of mechanically ventilated severe acute respiratory syndrome
(SARS) patients in the isolation intensive care unit (ICU). We
sought to determine whether pneumothoraces are induced by
high ventilatory pressure or volume and if they are associated
with mortality in mechanically ventilated SARS patients.
Methods We conducted a prospective, clinical study. Forty-one
mechanically ventilated SARS patients were included in our
study. All SARS patients were sedated and received mechanical
ventilation in the isolation ICU.
Results The mechanically ventilated SARS patients were
divided into two groups either with or without pneumothorax.
Their demographic data, clinical characteristics, ventilatory
variables such as positive end-expiratory pressure, peak
inspiratory pressure, mean airway pressure, tidal volume, tidal
volume per kilogram, respiratory rate and minute ventilation and
the accumulated mortality rate at 30 days after mechanical
ventilation were analyzed. There were no statistically significant
differences in the pressures and volumes between the two
groups, and the mortality was also similar between the groups.
However, patients developing pneumothorax during mechanical
ventilation frequently expressed higher respiratory rates on
admission, and a lower PaO2/FiO2 ratio and higher PaCO2 level
during hospitalization compared with those without
pneumothorax.
Conclusion In our study, the SARS patients who suffered
pneumothorax presented as more tachypnic on admission, and
more pronounced hypoxemic and hypercapnic during
hospitalization. These variables signaled a deterioration in
respiratory function and could be indicators of developing
pneumothorax during mechanical ventilation in the SARS
patients. Meanwhile, meticulous respiratory therapy and
monitoring were mandatory in these patients.
Introduction
Severe acute respiratory syndrome (SARS) is a transmissible
pulmonary infection caused by a novel coronavirus [1,2].
About 20 to 30% of SARS patients may progress to severe
hypoxemic respiratory failure that requires mechanical ventila-
tion and intensive care unit (ICU) admission [3-6]. Pneumoth-
orax, a major and potentially lethal complication of SARS and
mechanical ventilation, often complicates the management of
mechanically ventilated patients, and would be especially haz-
ardous for patients in an individually isolated SARS ICU. Peiris
et al. identified a high incidence of pneumomediastinum (12%)
in a general population of SARS patients [3]. In addition, LewR440
ALI = acute lung injury; APACHE = Acute Physiology and Chronic Health Evaluation; ARDS = acute respiratory distress syndrome; FiO2 = fraction 
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(20 to 34%) in mechanically ventilated SARS patients [6,7].
However, no further investigations have assessed the risk fac-
tors of pneumothorax in the mechanically ventilated SARS
patients.
Patients with acute respiratory distress syndrome (ARDS) and
acute lung injury (ALI) [8] developing pneumothorax have been
extensively studied. Previous studies have found that high
inspiratory airway pressure and positive end-expiratory pres-
sure (PEEP) were correlated with barotraumas [9-11]. Eisner
et al. analyzed a cohort of 718 patients with ALI/ARDS and
revealed that higher PEEP was related to an increased risk of
barotraumas [12]. However, others were unable to identify any
relationship between barotrauma and high ventilatory pressure
or volume in patients with early ARDS [13-15]. Therefore, the
relationship between airway pressure or volume and the devel-
opment of barotraumas remains uncertain.
To our knowledge, there is no study on the risk factors of pneu-
mothorax in mechanically ventilated SARS patients. To
address this issue, we performed a prospective study to deter-
mine whether pneumothorax was produced by high ventilatory
pressure or volume, and if it was associated with an increased
mortality rate at 30 days after mechanical ventilation.
Materials and methods
This study included patients with SARS who were admitted to
an isolation ICU at Taipei Veterans General Hospital. All
patients satisfied the WHO case definition for SARS [16]. The
research ethics board approved the study and we enrolled 41
patients with SARS who received mechanical ventilation
between 14 May 2003 and 18 July 2003. Patients with pre-
existing pneumothorax or chest tube thoracostomy were
excluded. The primary study outcome variable was defined as
radiographic evidence of new-onset pneumothorax at 30 days
after ventilator use. Patients were censored at the first pneu-
mothorax event, at the time of death, liberation from mechani-
cal ventilation or discharge from the SARS ICU. Patients
receiving mechanical ventilation were sedated with midazolam
or propofol to facilitate mechanical ventilation; meanwhile, the
sedatives were adjusted according to the Ramsay sedation
score. Moreover, atracurium was used for neuromuscular
paralysis to facilitate patient-ventilator synchrony in some
patients. The dosage of atracurium was adjusted by peripheral
nerve stimulator. When the patient was ready for weaning
according to defined criteria, sedation and/or neuromuscular
paralysis were discontinued.
Patient sex, age, actual body weight, APACHE II score and
pre-existing comorbidities were recorded at entry. The PaO2/
FiO2 ratio, PaO2, PaCO2, FiO2 and lung injury score [17] were
recorded on ICU admission and daily during hospitalization.
Ventilatory variables including PEEP, peak inspiratory pres-
sure (PIP), mean airway pressure (MAP), tidal volume, tidal vol-
ume per kilogram, respiratory rate and minute ventilation were
recorded at least once a day during the period of mechanical
ventilation. When pneumothorax occurred, the highest pres-
sure or volume of mechanical ventilation before the onset of
pneumothorax were most likely to be the cause of pneumoth-
orax [14]. Therefore, we compared the highest value of pres-
sure and volume within a 24-hour period before the event in
the patients with pneumothorax, with the overall values during
mechanical ventilation in patients without pneumothorax.
Data were presented as mean ± standard deviation. The
Mann-Whitney U test was used to compare data between
patients with and without pneumothorax. We compared risk
factors associated with the development of pneumothorax by
Fisher's exact test for categorical variables. Non-parametric
tests were chosen because of the small sample size in the
pneumothorax group. Kaplan-Meier survival curves were com-
pared by using the log-rank test. A p value of less than 0.05
was considered to indicate statistical significance. We used
SPSS software (v10.0) for all analyses.
Results
Demographic and clinical characteristics are shown in Table
1. Of the 41 patients, the male-to-female ratio was 1:0.37 and
mean age was 75.4 years. Five patients developed pneumot-
horax and the incidence of pneumothorax was 12%. The mean
time to the development of pneumothorax was 8.0 ± 4.4 days
after ventilator use. Of the patients, 28 (68%) met the criteria
for either ALI or ARDS. Patients with pneumothorax were sig-
nificantly associated with higher respiratory rate on admission,
and more pronounced hypoxemia with lower PaO2/FiO2 ratio
and higher PaCO2 during hospitalization.
Table 2 compares ventilator variables according to the pres-
ence or absence of pneumothorax. There were no significant
differences in any pressure or volume between the patients
with and without pneumothorax.
The overall survival rate was 59% at 30 days after mechanical
ventilation. The relationship between pneumothorax and the
probability of survival is shown in Fig. 1. There were no signif-
icant differences between the patients with and without
pneumothorax.
Discussion
In the present study, we focused on the mechanically venti-
lated SARS patients and analyzed the risk factors of pneumot-
horax. Our study demonstrated that mechanically ventilated
SARS patients with higher baseline respiratory rate, lower
PaO2/FiO2 ratio, and higher PaCO2 during hospitalization
were at a greater risk of developing pneumothorax. There were
no significant differences in pressure, volume and mortality
rate between the patients without and with pneumothorax.
Barotrauma is a common complication in patients with SARS.
The previous study by Peiris identified a high incidence of
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Demographic and clinical characteristics according to the presence or absence of pneumothorax
Variable No pneumothorax Pneumothorax p value
Number of patients (%) 36 (88) 5 (12)
Gender (male/female) 26/10 4/1 1
Age, years 76.3 ± 10.4 68.8 ± 18.0 0.46
Body weight, kg 58.5 ± 12.4 57.0 ± 18.2 0.98
APACHE II score 20.7 ± 6.6 26.0 ± 11.8 0.41
Pre-existing comorbidities
Chronic renal insufficiency 4 0 1
Congestive heart failure 9 2 0.59
Diabetes mellitus 15 2 1
Chronic obstructive pulmonary disease 5 0 1
Pulmonary tuberculosis 2 2 0.06
Cerebrovascular disease 17 1 0.37
On ICU admission
Baseline lung injury score 1.27 ± 1.04 1.59 ± 0.59 0.35
Baseline respiratory rate 25.32 ± 7.53 36.00 ± 5.10 0.006
Baseline PaO2/FiO2 ratio 289.9 ± 172.9 272.6 ± 140.8 0.87
Baseline PaCO2 35.7 ± 9.3 49.4 ± 23.0 0.20
During hospitalization
Highest lung injury score 1.59 ± 1.10 2.51 ± 0.29 0.09
Highest respiratory rate 34.65 ± 5.19 40.80 ± 7.08 0.06
Lowest PaO2/FiO2 ratio 210.1 ± 123.8 65.8 ± 24.3 0.02
Highest PaCO2 49.9 ± 17.4 80.1 ± 12.3 0.004
ALI/ARDS (%) 24 (66%) 4 (80%) 1
Liberation from ventilator (%) at 30 days 11(31) 0 0.29
Data are presented as mean ± standard deviation. ALI, acute lung injury; APACHE, Acute Physiology and Chronic Health Evaluation; ARDS, acute 
respiratory distress syndrome; FiO2, fraction of inspired oxygen; ICU, intensive care unit; PEEP, positive end-expiratory pressure.
Table 2
The ventilator variables according to the presence or absence of pneumothorax
Variables No pneumothorax Pneumothorax p
Ventilatory pressure, cmH2O, or volume
positive end-expiratory pressure 7.94 ± 4.38 8.2 ± 2.0 0.54
peak inspiratory pressure 34.78 ± 6.80 33.8 ± 3.76 0.73
mean airway pressure 18.75 ± 4.89 20.8 ± 1.78 0.17
tidal volume, ml 761.02 ± 128.87 733.8 ± 154.0 0.43
tidal volume/kg, ml 12.32 ± 2.71 12.54 ± 3.34 0.97
Minute ventilation, l (on ICU admission) 10.40 ± 3.00 11.38 ± 2.84 0.34
Minute ventilation, l (during hospitalization) 15.33 ± 4.68 12.93 ± 4.10 0.26
Data are presented as mean ± standard deviation.
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patients [3]. Choi et al. had also shown that subcutaneous
emphysema, pneumothorax and pneumomediastinum were
detected in six SARS patients (2.2%) who had not received
positive-pressure ventilation [18].
In our study, the incidence of pneumothorax in mechanically
ventilated SARS patients was lower than previous studies
(12% versus 20 to 34%) [6,7]. The incidence of barotrauma
in patients with ALI/ARDS varies widely. In most recent stud-
ies, it has ranged from 5 to 15% [12,14,19]. Gammon and col-
leagues have shown that the presence of ARDS is the major
independent risk factor of barotraumas [13,20]. This may
explain the lower incidence of pneumothorax in our study since
the proportion of our patients with ALI/ARDS (68%) is lower
than the other studies [6,7].
Another important finding in our study was the lack of correla-
tion between ventilator variables and the presence of pneu-
mothorax. Our results agreed with most of the previous studies
that were done on ARDS patients. In the ARDS Network ran-
domized controlled trial, low tidal volume ventilation decreased
mortality without influencing the incidence of barotraumas
[19]. In patients with sepsis-induced ARDS, there were no sig-
nificant correlations between the ventilatory parameters and
the development of pneumothorax or another air leak [14].
These authors suggested that barotrauma was more related to
the underlying process than to the ventilator settings [14,15].
We found that the mechanically ventilated SARS patients with
pneumothorax had a significant baseline tachypnea. Addition-
ally, patients with a higher respiratory rate on admission also
showed a trend of higher respiratory rate during
hospitalization. (p = 0.06). Tachypnea on admission probably
reflected the increased severity of the underlying disease [21],
which may directly lead to a higher incidence of pneumotho-
rax. There was also a higher risk of auto-PEEP in patients with
tachypnea due to insufficient expiratory time, which may also
contribute to the development of pneumothorax. However,
auto-PEEP was not recorded in this study.
In our study, SARS patients with pneumothorax had a higher
PaCO2 during hospitalization. Gattinoni et al. also observed a
similar finding in ARDS patients with pneumothorax [11].
Increased dead space and cystic changes of lung parenchyma
due to worsening underlying disease played a major role in
patients with hypercapnia. This mechanism is further sup-
ported by a thin-section computed tomographic study that
was done by Joynt and colleagues on the late stage of ARDS
(more than 2 weeks after onset) caused by SARS [22]. They
found that severe SARS-induced ARDS might independently
result in cyst formation. In our study, patients with pneumoth-
orax were also associated with a more pronounced hypox-
emia, with lower PaO2/FiO2 during hospitalization compared
with those without pneumothorax (65.8 versus 210.1). Oxy-
gen-diffusing impairment and ventilation-perfusion maldistribu-
tion may play a role in developing hypoxemia in the
mechanically ventilated SARS patient. A decrease in PaO2/
FiO2 and increase in PaCO2 may be considered as a deterio-
ration of respiratory condition in a patient with ALI/ARDS. The
presence of pneumothorax together with hypoxemia/hyper-
capnia may indicate worsening of the underlying disease. This
is supported by the large difference in APACHE II (26.0 ±
11.8 versus 20.7 ± 6.6) and ALI (2.51 ± 0.29 versus 1.59 ±
1.10) scores between patients with and without pneumotho-
rax in this study, although these did not reach statistical
significance.
In our study, the mortality rate was not significantly increased
in patients with pneumothorax. In other studies on ALI/ARDS,
the mortality directly attributable to barotrauma was low
[12,14,23]. The mortality rate was 41% in our study, which
was higher than the 26% from the results of five cohort studies
[2-4,24,25]. Older age and more comorbidities may be the
major causes. Age and coexisting illness, especially diabetes
mellitus and heart disease, were consistently found to be
independent prognostic factors for the risk of death and the
need for intensive care in SARS patients [3-5,26,27].
There are several limitations to our study. Data were recorded
once daily in individual isolation rooms and may have missed
transient elevations in airway pressure/volume that could have
led to alveolar disruption and pneumothorax. Secondly, we
selected parameters that were easily measured and were
previously shown or theorized to contribute to alveolar disrup-
tion, including ventilator variables and high-risk disease states.
However, it is possible that an important variable such as pla-
teau pressure was omitted from this analysis. Thirdly, there
were only 41 mechanically ventilated SARS patients in our
Figure 1
Kaplan-Meier curve of the probability of survival over time for mechani-c lly ventilated SARS patients
cally ventilated SARS patients. (p = 0.11).
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tistical significance. The above factors are likely to cloud the
relationship between the ventilatory variables and the occur-
rence of barotrauma.
Conclusion
The analysis of pneumothorax in mechanically ventilated
SARS patients indicates that the patients with higher respira-
tory rates on admission, and lower PaO2/FiO2 ratio and higher
PaCO2 during hospitalization had a greater risk of pneumoth-
orax. The correlation between the clinical characteristics and
pneumothorax may be considered as a deterioration of respi-
ratory function in mechanically ventilated SARS patients
developing pneumothorax. Pneumothorax in mechanically ven-
tilated SARS patients may be an indicator of worsening under-
lying lung disease.
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risk of developing pneumothorax.
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